About Polycomb protein EED
Polycomb protein EED (EED) is a protein
from Homo sapiens identified by UniProt accession
O75530, 441 residues long.
MolForge cross-references it against 0 known binders and
247 disease associations.
Target properties
| Protein name | Polycomb protein EED |
| UniProt accession | O75530 |
| Gene | EED |
| Organism | Homo sapiens |
| Length | 441 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (2)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (247)
Diseases linked to this target (Open Targets).
- Cohen-Gibson syndrome · score 0.78
- viral disease · score 0.46
- melanoma · score 0.42
- breast carcinoma · score 0.42
- cancer · score 0.38
- platelet component distribution width · score 0.33
- acute myeloid leukemia · score 0.30
- breast adenocarcinoma · score 0.28
- head and neck squamous cell carcinoma · score 0.28
- autism spectrum disorder · score 0.27
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O75530-F1 | alphafold | PREDICTED | 86.48 | — |
Amino-acid sequence (441 residues)
MSEREVSTAP AGTDMPAAKK QKLSSDENSN PDLSGDENDD AVSIESGTNT ERPDTPTNTP NAPGRKSWGK GKWKSKKCKY SFKCVNSLKE DHNQPLFGVQ FNWHSKEGDP LVFATVGSNR VTLYECHSQG EIRLLQSYVD ADADENFYTC AWTYDSNTSH PLLAVAGSRG IIRIINPITM QCIKHYVGHG NAINELKFHP RDPNLLLSVS KDHALRLWNI QTDTLVAIFG GVEGHRDEVL SADYDLLGEK IMSCGMDHSL KLWRINSKRM MNAIKESYDY NPNKTNRPFI SQKIHFPDFS TRDIHRNYVD CVRWLGDLIL SKSCENAIVC WKPGKMEDDI DKIKPSESNV TILGRFDYSQ CDIWYMRFSM DFWQKMLALG NQVGKLYVWD LEVEDPHKAK CTTLTHHKCG AAIRQTSFSR DSSILIAVCD DASIWRWDRL R
Explore Polycomb protein EED with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets